Table of Content

1 Anti-obesity Drugs Market Overview
1.1 Anti-obesity Drugs Product Overview
1.2 Anti-obesity Drugs Market Segment by Type
1.2.1 Peripherally Acting Anti-obesity Drugs
1.2.2 Centrally Acting Anti-obesity Drugs
1.3 Global Anti-obesity Drugs Market Size by Type
1.3.1 Global Anti-obesity Drugs Market Size Overview by Type (2024-2034)
1.3.2 Global Anti-obesity Drugs Historic Market Size Review by Type (2024-2024)
1.3.3 Global Anti-obesity Drugs Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Anti-obesity Drugs Sales Breakdown by Type (2024-2024)
1.4.2 Europe Anti-obesity Drugs Sales Breakdown by Type (2024-2024)
1.4.3 Asia-Pacific Anti-obesity Drugs Sales Breakdown by Type (2024-2024)
1.4.4 Latin America Anti-obesity Drugs Sales Breakdown by Type (2024-2024)
1.4.5 Middle East and Africa Anti-obesity Drugs Sales Breakdown by Type (2024-2024)
2 Global Anti-obesity Drugs Market Competition by Company
2.1 Global Top Players by Anti-obesity Drugs Sales (2024-2024)
2.2 Global Top Players by Anti-obesity Drugs Revenue (2024-2024)
2.3 Global Top Players by Anti-obesity Drugs Price (2024-2024)
2.4 Global Top Manufacturers Anti-obesity Drugs Manufacturing Base Distribution, Sales Area, Product Type
2.5 Anti-obesity Drugs Market Competitive Situation and Trends
2.5.1 Anti-obesity Drugs Market Concentration Rate (2024-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Anti-obesity Drugs Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Anti-obesity Drugs as of 2022)
2.7 Date of Key Manufacturers Enter into Anti-obesity Drugs Market
2.8 Key Manufacturers Anti-obesity Drugs Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Anti-obesity Drugs Status and Outlook by Region
3.1 Global Anti-obesity Drugs Market Size and CAGR by Region: 2024 VS 2022 VS 2034
3.2 Global Anti-obesity Drugs Historic Market Size by Region
3.2.1 Global Anti-obesity Drugs Sales in Volume by Region (2024-2024)
3.2.2 Global Anti-obesity Drugs Sales in Value by Region (2024-2024)
3.2.3 Global Anti-obesity Drugs Sales (Volume & Value) Price and Gross Margin (2024-2024)
3.3 Global Anti-obesity Drugs Forecasted Market Size by Region
3.3.1 Global Anti-obesity Drugs Sales in Volume by Region (2024-2034)
3.3.2 Global Anti-obesity Drugs Sales in Value by Region (2024-2034)
3.3.3 Global Anti-obesity Drugs Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Anti-obesity Drugs by Application
4.1 Anti-obesity Drugs Market Segment by Application
4.1.1 Kids
4.1.2 Adults
4.2 Global Anti-obesity Drugs Market Size by Application
4.2.1 Global Anti-obesity Drugs Market Size Overview by Application (2024-2034)
4.2.2 Global Anti-obesity Drugs Historic Market Size Review by Application (2024-2024)
4.2.3 Global Anti-obesity Drugs Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Anti-obesity Drugs Sales Breakdown by Application (2024-2024)
4.3.2 Europe Anti-obesity Drugs Sales Breakdown by Application (2024-2024)
4.3.3 Asia-Pacific Anti-obesity Drugs Sales Breakdown by Application (2024-2024)
4.3.4 Latin America Anti-obesity Drugs Sales Breakdown by Application (2024-2024)
4.3.5 Middle East and Africa Anti-obesity Drugs Sales Breakdown by Application (2024-2024)
5 North America Anti-obesity Drugs by Country
5.1 North America Anti-obesity Drugs Historic Market Size by Country
5.1.1 North America Anti-obesity Drugs Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
5.1.2 North America Anti-obesity Drugs Sales in Volume by Country (2024-2024)
5.1.3 North America Anti-obesity Drugs Sales in Value by Country (2024-2024)
5.2 North America Anti-obesity Drugs Forecasted Market Size by Country
5.2.1 North America Anti-obesity Drugs Sales in Volume by Country (2024-2034)
5.2.2 North America Anti-obesity Drugs Sales in Value by Country (2024-2034)
6 Europe Anti-obesity Drugs by Country
6.1 Europe Anti-obesity Drugs Historic Market Size by Country
6.1.1 Europe Anti-obesity Drugs Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
6.1.2 Europe Anti-obesity Drugs Sales in Volume by Country (2024-2024)
6.1.3 Europe Anti-obesity Drugs Sales in Value by Country (2024-2024)
6.2 Europe Anti-obesity Drugs Forecasted Market Size by Country
6.2.1 Europe Anti-obesity Drugs Sales in Volume by Country (2024-2034)
6.2.2 Europe Anti-obesity Drugs Sales in Value by Country (2024-2034)
7 Asia-Pacific Anti-obesity Drugs by Region
7.1 Asia-Pacific Anti-obesity Drugs Historic Market Size by Region
7.1.1 Asia-Pacific Anti-obesity Drugs Market Size Growth Rate (CAGR) by Region: 2024 VS 2022 VS 2034
7.1.2 Asia-Pacific Anti-obesity Drugs Sales in Volume by Region (2024-2024)
7.1.3 Asia-Pacific Anti-obesity Drugs Sales in Value by Region (2024-2024)
7.2 Asia-Pacific Anti-obesity Drugs Forecasted Market Size by Region
7.2.1 Asia-Pacific Anti-obesity Drugs Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Anti-obesity Drugs Sales in Value by Region (2024-2034)
8 Latin America Anti-obesity Drugs by Country
8.1 Latin America Anti-obesity Drugs Historic Market Size by Country
8.1.1 Latin America Anti-obesity Drugs Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
8.1.2 Latin America Anti-obesity Drugs Sales in Volume by Country (2024-2024)
8.1.3 Latin America Anti-obesity Drugs Sales in Value by Country (2024-2024)
8.2 Latin America Anti-obesity Drugs Forecasted Market Size by Country
8.2.1 Latin America Anti-obesity Drugs Sales in Volume by Country (2024-2034)
8.2.2 Latin America Anti-obesity Drugs Sales in Value by Country (2024-2034)
9 Middle East and Africa Anti-obesity Drugs by Country
9.1 Middle East and Africa Anti-obesity Drugs Historic Market Size by Country
9.1.1 Middle East and Africa Anti-obesity Drugs Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
9.1.2 Middle East and Africa Anti-obesity Drugs Sales in Volume by Country (2024-2024)
9.1.3 Middle East and Africa Anti-obesity Drugs Sales in Value by Country (2024-2024)
9.2 Middle East and Africa Anti-obesity Drugs Forecasted Market Size by Country
9.2.1 Middle East and Africa Anti-obesity Drugs Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Anti-obesity Drugs Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Merck
10.1.1 Merck Company Information
10.1.2 Merck Introduction and Business Overview
10.1.3 Merck Anti-obesity Drugs Sales, Revenue and Gross Margin (2024-2024)
10.1.4 Merck Anti-obesity Drugs Products Offered
10.1.5 Merck Recent Development
10.2 Novo Nordisk
10.2.1 Novo Nordisk Company Information
10.2.2 Novo Nordisk Introduction and Business Overview
10.2.3 Novo Nordisk Anti-obesity Drugs Sales, Revenue and Gross Margin (2024-2024)
10.2.4 Novo Nordisk Anti-obesity Drugs Products Offered
10.2.5 Novo Nordisk Recent Development
10.3 Pfizer
10.3.1 Pfizer Company Information
10.3.2 Pfizer Introduction and Business Overview
10.3.3 Pfizer Anti-obesity Drugs Sales, Revenue and Gross Margin (2024-2024)
10.3.4 Pfizer Anti-obesity Drugs Products Offered
10.3.5 Pfizer Recent Development
10.4 Arena Pharmaceuticals
10.4.1 Arena Pharmaceuticals Company Information
10.4.2 Arena Pharmaceuticals Introduction and Business Overview
10.4.3 Arena Pharmaceuticals Anti-obesity Drugs Sales, Revenue and Gross Margin (2024-2024)
10.4.4 Arena Pharmaceuticals Anti-obesity Drugs Products Offered
10.4.5 Arena Pharmaceuticals Recent Development
10.5 Roche
10.5.1 Roche Company Information
10.5.2 Roche Introduction and Business Overview
10.5.3 Roche Anti-obesity Drugs Sales, Revenue and Gross Margin (2024-2024)
10.5.4 Roche Anti-obesity Drugs Products Offered
10.5.5 Roche Recent Development
10.6 GlaxoSmithKline
10.6.1 GlaxoSmithKline Company Information
10.6.2 GlaxoSmithKline Introduction and Business Overview
10.6.3 GlaxoSmithKline Anti-obesity Drugs Sales, Revenue and Gross Margin (2024-2024)
10.6.4 GlaxoSmithKline Anti-obesity Drugs Products Offered
10.6.5 GlaxoSmithKline Recent Development
10.7 Orexigen Therapeutics
10.7.1 Orexigen Therapeutics Company Information
10.7.2 Orexigen Therapeutics Introduction and Business Overview
10.7.3 Orexigen Therapeutics Anti-obesity Drugs Sales, Revenue and Gross Margin (2024-2024)
10.7.4 Orexigen Therapeutics Anti-obesity Drugs Products Offered
10.7.5 Orexigen Therapeutics Recent Development
10.8 Vivus
10.8.1 Vivus Company Information
10.8.2 Vivus Introduction and Business Overview
10.8.3 Vivus Anti-obesity Drugs Sales, Revenue and Gross Margin (2024-2024)
10.8.4 Vivus Anti-obesity Drugs Products Offered
10.8.5 Vivus Recent Development
10.9 Amylin
10.9.1 Amylin Company Information
10.9.2 Amylin Introduction and Business Overview
10.9.3 Amylin Anti-obesity Drugs Sales, Revenue and Gross Margin (2024-2024)
10.9.4 Amylin Anti-obesity Drugs Products Offered
10.9.5 Amylin Recent Development
10.10 Alizyme
10.10.1 Alizyme Company Information
10.10.2 Alizyme Introduction and Business Overview
10.10.3 Alizyme Anti-obesity Drugs Sales, Revenue and Gross Margin (2024-2024)
10.10.4 Alizyme Anti-obesity Drugs Products Offered
10.10.5 Alizyme Recent Development
10.11 Boehringer Ingelheim
10.11.1 Boehringer Ingelheim Company Information
10.11.2 Boehringer Ingelheim Introduction and Business Overview
10.11.3 Boehringer Ingelheim Anti-obesity Drugs Sales, Revenue and Gross Margin (2024-2024)
10.11.4 Boehringer Ingelheim Anti-obesity Drugs Products Offered
10.11.5 Boehringer Ingelheim Recent Development
10.12 Eisai
10.12.1 Eisai Company Information
10.12.2 Eisai Introduction and Business Overview
10.12.3 Eisai Anti-obesity Drugs Sales, Revenue and Gross Margin (2024-2024)
10.12.4 Eisai Anti-obesity Drugs Products Offered
10.12.5 Eisai Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Anti-obesity Drugs Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Anti-obesity Drugs Industrial Chain Analysis
11.4 Anti-obesity Drugs Market Dynamics
11.4.1 Anti-obesity Drugs Industry Trends
11.4.2 Anti-obesity Drugs Market Drivers
11.4.3 Anti-obesity Drugs Market Challenges
11.4.4 Anti-obesity Drugs Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Anti-obesity Drugs Distributors
12.3 Anti-obesity Drugs Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Peripherally Acting Anti-obesity Drugs
Table 2. Major Company of Centrally Acting Anti-obesity Drugs
Table 3. Global Anti-obesity Drugs Sales by Type 2024 VS 2022 VS 2034 (US$ Million)
Table 4. Global Anti-obesity Drugs Sales by Type (2024-2024) & (K Units)
Table 5. Global Anti-obesity Drugs Sales Market Share in Volume by Type (2024-2024)
Table 6. Global Anti-obesity Drugs Sales by Type (2024-2024) & (US& Million)
Table 7. Global Anti-obesity Drugs Market Share in Value by Type (2024-2024)
Table 8. Global Anti-obesity Drugs Price by Type (2024-2024) & (USD/Unit)
Table 9. Global Anti-obesity Drugs Sales by Type (2024-2034) & (K Units)
Table 10. Global Anti-obesity Drugs Sales Market Share in Volume by Type (2024-2034)
Table 11. Global Anti-obesity Drugs Sales by Type (2024-2034) & (US$ Million)
Table 12. Global Anti-obesity Drugs Sales Market Share in Value by Type (2024-2034)
Table 13. Global Anti-obesity Drugs Price by Type (2024-2034) & (USD/Unit)
Table 14. North America Anti-obesity Drugs Sales by Type (2024-2024) & (K Units)
Table 15. North America Anti-obesity Drugs Sales by Type (2024-2024) & (US$ Million)
Table 16. Europe Anti-obesity Drugs Sales (K Units) by Type (2024-2024)
Table 17. Europe Anti-obesity Drugs Sales by Type (2024-2024) & (US$ Million)
Table 18. Asia-Pacific Anti-obesity Drugs Sales (K Units) by Type (2024-2024)
Table 19. Asia-Pacific Anti-obesity Drugs Sales by Type (2024-2024) & (US$ Million)
Table 20. Latin America Anti-obesity Drugs Sales (K Units) by Type (2024-2024)
Table 21. Latin America Anti-obesity Drugs Sales by Type (2024-2024) & (US$ Million)
Table 22. Middle East and Africa Anti-obesity Drugs Sales (K Units) by Type (2024-2024)
Table 23. Middle East and Africa Anti-obesity Drugs Sales by Type (2024-2024) & (US$ Million)
Table 24. Global Anti-obesity Drugs Sales by Company (2024-2024) & (K Units)
Table 25. Global Anti-obesity Drugs Sales Share by Company (2024-2024)
Table 26. Global Anti-obesity Drugs Revenue by Company (2024-2024) & (US$ Million)
Table 27. Global Anti-obesity Drugs Revenue Share by Company (2024-2024)
Table 28. Global Market Anti-obesity Drugs Price by Company (2024-2024) & (USD/Unit)
Table 29. Global Anti-obesity Drugs Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 30. Global Anti-obesity Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 31. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Anti-obesity Drugs as of 2022)
Table 32. Date of Key Manufacturers Enter into Anti-obesity Drugs Market
Table 33. Key Manufacturers Anti-obesity Drugs Product Type
Table 34. Mergers & Acquisitions, Expansion Plans
Table 35. Global Anti-obesity Drugs Market Size Comparison by Region (US$ Million): 2024 VS 2022 VS 2034
Table 36. Global Anti-obesity Drugs Sales by Region (2024-2024) & (K Units)
Table 37. Global Anti-obesity Drugs Sales Market Share in Volume by Region (2024-2024)
Table 38. Global Anti-obesity Drugs Sales by Region (2024-2024) & (US$ Million)
Table 39. Global Anti-obesity Drugs Sales Market Share in Value by Region (2024-2024)
Table 40. Global Anti-obesity Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2024-2024)
Table 41. Global Anti-obesity Drugs Sales by Region (2024-2034) & (K Units)
Table 42. Global Anti-obesity Drugs Sales Market Share in Volume by Region (2024-2034)
Table 43. Global Anti-obesity Drugs Sales by Region (2024-2034) & (US$ Million)
Table 44. Global Anti-obesity Drugs Sales Market Share in Value by Region (2024-2034)
Table 45. Global Anti-obesity Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2024-2034)
Table 46. Global Anti-obesity Drugs Sales by Application: 2024 VS 2022 VS 2034 (US$ Million)
Table 47. Global Anti-obesity Drugs Sales by Application (2024-2024) & (K Units)
Table 48. Global Anti-obesity Drugs Sales Market Share in Volume by Application (2024-2024)
Table 49. Global Anti-obesity Drugs Sales by Application (2024-2024) & (US$ Million)
Table 50. Global Anti-obesity Drugs Sales Market Share in Value by Application (2024-2024)
Table 51. Global Anti-obesity Drugs Price by Application (2024-2024) & (USD/Unit)
Table 52. Global Anti-obesity Drugs Sales by Application (2024-2034) & (K Units)
Table 53. Global Anti-obesity Drugs Sales Market Share in Volume by Application (2024-2034)
Table 54. Global Anti-obesity Drugs Sales by Application (2024-2034) & (US$ Million)
Table 55. Global Anti-obesity Drugs Sales Market Share in Value by Application (2024-2034)
Table 56. Global Anti-obesity Drugs Price by Application (2024-2034) & (USD/Unit)
Table 57. North America Anti-obesity Drugs Sales by Application (2024-2024) (K Units)
Table 58. North America Anti-obesity Drugs Sales by Application (2024-2024) & (US$ Million)
Table 59. Europe Anti-obesity Drugs Sales by Application (2024-2024) (K Units)
Table 60. Europe Anti-obesity Drugs Sales by Application (2024-2024) & (US$ Million)
Table 61. Asia-Pacific Anti-obesity Drugs Sales by Application (2024-2024) (K Units)
Table 62. Asia-Pacific Anti-obesity Drugs Sales by Application (2024-2024) & (US$ Million)
Table 63. Latin America Anti-obesity Drugs Sales by Application (2024-2024) (K Units)
Table 64. Latin America Anti-obesity Drugs Sales by Application (2024-2024) & (US$ Million)
Table 65. Middle East and Africa Anti-obesity Drugs Sales by Application (2024-2024) (K Units)
Table 66. Middle East and Africa Anti-obesity Drugs Sales by Application (2024-2024) & (US$ Million)
Table 67. North America Anti-obesity Drugs Sales by Country (2024-2024) & (K Units)
Table 68. North America Anti-obesity Drugs Sales Market Share in Volume by Country (2024-2024)
Table 69. North America Anti-obesity Drugs Sales by Country (2024-2024) & (US$ Million)
Table 70. North America Anti-obesity Drugs Sales Market Share in Value by Country (2024-2024)
Table 71. North America Anti-obesity Drugs Sales by Country (2024-2034) & (K Units)
Table 72. North America Anti-obesity Drugs Sales Market Share in Volume by Country (2024-2034)
Table 73. North America Anti-obesity Drugs Sales by Country (2024-2034) & (US$ Million)
Table 74. North America Anti-obesity Drugs Sales Market Share in Value by Country (2024-2034)
Table 75. Europe Anti-obesity Drugs Sales by Country (2024-2024) & (K Units)
Table 76. Europe Anti-obesity Drugs Sales Market Share in Volume by Country (2024-2024)
Table 77. Europe Anti-obesity Drugs Sales by Country (2024-2024) & (US$ Million)
Table 78. Europe Anti-obesity Drugs Sales Market Share in Value by Country (2024-2024)
Table 79. Europe Anti-obesity Drugs Sales by Country (2024-2034) & (K Units)
Table 80. Europe Anti-obesity Drugs Sales Market Share in Volume by Country (2024-2034)
Table 81. Europe Anti-obesity Drugs Sales by Country (2024-2034) & (US$ Million)
Table 82. Europe Anti-obesity Drugs Sales Market Share in Value by Country (2024-2034)
Table 83. Asia-Pacific Anti-obesity Drugs Sales by Region (2024-2024) & (K Units)
Table 84. Asia-Pacific Anti-obesity Drugs Sales Market Share in Volume by Region (2024-2024)
Table 85. Asia-Pacific Anti-obesity Drugs Sales by Region (2024-2024) & (US$ Million)
Table 86. Asia-Pacific Anti-obesity Drugs Sales Market Share in Value by Region (2024-2024)
Table 87. Asia-Pacific Anti-obesity Drugs Sales by Region (2024-2034) & (K Units)
Table 88. Asia-Pacific Anti-obesity Drugs Sales Market Share in Volume by Region (2024-2034)
Table 89. Asia-Pacific Anti-obesity Drugs Sales by Region (2024-2034) & (US$ Million)
Table 90. Asia-Pacific Anti-obesity Drugs Sales Market Share in Value by Region (2024-2034)
Table 91. Latin America Anti-obesity Drugs Sales by Country (2024-2024) & (K Units)
Table 92. Latin America Anti-obesity Drugs Sales Market Share in Volume by Country (2024-2024)
Table 93. Latin America Anti-obesity Drugs Sales by Country (2024-2024) & (US$ Million)
Table 94. Latin America Anti-obesity Drugs Sales Market Share in Value by Country (2024-2024)
Table 95. Latin America Anti-obesity Drugs Sales by Country (2024-2034) & (K Units)
Table 96. Latin America Anti-obesity Drugs Sales Market Share in Volume by Country (2024-2034)
Table 97. Latin America Anti-obesity Drugs Sales by Country (2024-2034) & (US$ Million)
Table 98. Latin America Anti-obesity Drugs Sales Market Share in Value by Country (2024-2034)
Table 99. Middle East and Africa Anti-obesity Drugs Sales by Country (2024-2024) & (K Units)
Table 100. Middle East and Africa Anti-obesity Drugs Sales Market Share in Volume by Country (2024-2024)
Table 101. Middle East and Africa Anti-obesity Drugs Sales by Country (2024-2024) & (US$ Million)
Table 102. Middle East and Africa Anti-obesity Drugs Sales Market Share in Value by Country (2024-2024)
Table 103. Middle East and Africa Anti-obesity Drugs Sales by Country (2024-2034) & (K Units)
Table 104. Middle East and Africa Anti-obesity Drugs Sales Market Share in Volume by Country (2024-2034)
Table 105. Middle East and Africa Anti-obesity Drugs Sales by Country (2024-2034) & (US$ Million)
Table 106. Middle East and Africa Anti-obesity Drugs Sales Market Share in Value by Country (2024-2034)
Table 107. Merck Company Information
Table 108. Merck Introduction and Business Overview
Table 109. Merck Anti-obesity Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 110. Merck Anti-obesity Drugs Product
Table 111. Merck Recent Development
Table 112. Novo Nordisk Company Information
Table 113. Novo Nordisk Introduction and Business Overview
Table 114. Novo Nordisk Anti-obesity Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 115. Novo Nordisk Anti-obesity Drugs Product
Table 116. Novo Nordisk Recent Development
Table 117. Pfizer Company Information
Table 118. Pfizer Introduction and Business Overview
Table 119. Pfizer Anti-obesity Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 120. Pfizer Anti-obesity Drugs Product
Table 121. Pfizer Recent Development
Table 122. Arena Pharmaceuticals Company Information
Table 123. Arena Pharmaceuticals Introduction and Business Overview
Table 124. Arena Pharmaceuticals Anti-obesity Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 125. Arena Pharmaceuticals Anti-obesity Drugs Product
Table 126. Arena Pharmaceuticals Recent Development
Table 127. Roche Company Information
Table 128. Roche Introduction and Business Overview
Table 129. Roche Anti-obesity Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 130. Roche Anti-obesity Drugs Product
Table 131. Roche Recent Development
Table 132. GlaxoSmithKline Company Information
Table 133. GlaxoSmithKline Introduction and Business Overview
Table 134. GlaxoSmithKline Anti-obesity Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 135. GlaxoSmithKline Anti-obesity Drugs Product
Table 136. GlaxoSmithKline Recent Development
Table 137. Orexigen Therapeutics Company Information
Table 138. Orexigen Therapeutics Introduction and Business Overview
Table 139. Orexigen Therapeutics Anti-obesity Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 140. Orexigen Therapeutics Anti-obesity Drugs Product
Table 141. Orexigen Therapeutics Recent Development
Table 142. Vivus Company Information
Table 143. Vivus Introduction and Business Overview
Table 144. Vivus Anti-obesity Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 145. Vivus Anti-obesity Drugs Product
Table 146. Vivus Recent Development
Table 147. Amylin Company Information
Table 148. Amylin Introduction and Business Overview
Table 149. Amylin Anti-obesity Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 150. Amylin Anti-obesity Drugs Product
Table 151. Amylin Recent Development
Table 152. Alizyme Company Information
Table 153. Alizyme Introduction and Business Overview
Table 154. Alizyme Anti-obesity Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 155. Alizyme Anti-obesity Drugs Product
Table 156. Alizyme Recent Development
Table 157. Boehringer Ingelheim Company Information
Table 158. Boehringer Ingelheim Introduction and Business Overview
Table 159. Boehringer Ingelheim Anti-obesity Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 160. Boehringer Ingelheim Anti-obesity Drugs Product
Table 161. Boehringer Ingelheim Recent Development
Table 162. Eisai Company Information
Table 163. Eisai Introduction and Business Overview
Table 164. Eisai Anti-obesity Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 165. Eisai Anti-obesity Drugs Product
Table 166. Eisai Recent Development
Table 167. Key Raw Materials Lists
Table 168. Raw Materials Key Suppliers Lists
Table 169. Anti-obesity Drugs Market Trends
Table 170. Anti-obesity Drugs Market Drivers
Table 171. Anti-obesity Drugs Market Challenges
Table 172. Anti-obesity Drugs Market Restraints
Table 173. Anti-obesity Drugs Distributors List
Table 174. Anti-obesity Drugs Downstream Customers
Table 175. Research Programs/Design for This Report
Table 176. Key Data Information from Secondary Sources
Table 177. Key Data Information from Primary Sources
List of Figures
Figure 1. Anti-obesity Drugs Product Picture
Figure 2. Global Anti-obesity Drugs Market Size, 2024 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Anti-obesity Drugs Market Size Status and Outlook (2024-2034) & (US$ Million)
Figure 4. Global Anti-obesity Drugs Sales Status and Outlook (2024-2034) & (K Units)
Figure 5. Product Picture of Peripherally Acting Anti-obesity Drugs
Figure 6. Global Peripherally Acting Anti-obesity Drugs Sales YoY Growth (2024-2034) & (K Units)
Figure 7. Product Picture of Centrally Acting Anti-obesity Drugs
Figure 8. Global Centrally Acting Anti-obesity Drugs Sales YoY Growth (2024-2034) & (K Units)
Figure 9. Global Anti-obesity Drugs Sales by Type (2024-2034) & (US$ Million)
Figure 10. Global Anti-obesity Drugs Sales Market Share by Type in 2022 & 2034
Figure 11. North America Anti-obesity Drugs Sales Market Share in Volume by Type in 2022
Figure 12. North America Anti-obesity Drugs Sales Market Share in Value by Type in 2022
Figure 13. Europe Anti-obesity Drugs Sales Market Share in Volume by Type in 2022
Figure 14. Europe Anti-obesity Drugs Sales Market Share in Value by Type in 2022
Figure 15. Asia-Pacific Anti-obesity Drugs Sales Market Share in Volume by Type in 2022
Figure 16. Asia-Pacific Anti-obesity Drugs Sales Market Share in Value by Type in 2022
Figure 17. Latin America Anti-obesity Drugs Sales Market Share in Volume by Type in 2022
Figure 18. Latin America Anti-obesity Drugs Sales Market Share in Value by Type in 2022
Figure 19. Middle East and Africa Anti-obesity Drugs Sales Market Share in Volume by Type in 2022
Figure 20. Middle East and Africa Anti-obesity Drugs Sales Market Share in Value by Type in 2022
Figure 21. The 5 and 10 Largest Manufacturers in the World: Market Share by Anti-obesity Drugs Sales in 2022
Figure 22. The 5 and 10 Largest Manufacturers in the World: Market Share by Anti-obesity Drugs Revenue in 2022
Figure 23. Anti-obesity Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2024 VS 2022
Figure 24. Product Picture of Kids
Figure 25. Global Kids Sales YoY Growth (2024-2034) & (K Units)
Figure 26. Product Picture of Adults
Figure 27. Global Adults Sales YoY Growth (2024-2034) & (K Units)
Figure 28. Global Anti-obesity Drugs Sales by Application (2024-2034) & (US$ Million)
Figure 29. Global Anti-obesity Drugs Sales Market Share by Application in 2022 & 2034
Figure 30. North America Anti-obesity Drugs Sales Market Share in Volume by Application in 2022
Figure 31. North America Anti-obesity Drugs Sales Market Share in Value by Application in 2022
Figure 32. Europe Anti-obesity Drugs Sales Market Share in Volume by Application in 2022
Figure 33. Europe Anti-obesity Drugs Sales Market Share in Value by Application in 2022
Figure 34. Asia-Pacific Anti-obesity Drugs Sales Market Share in Volume by Application in 2022
Figure 35. Asia-Pacific Anti-obesity Drugs Sales Market Share in Value by Application in 2022
Figure 36. Latin America Anti-obesity Drugs Sales Market Share in Volume by Application in 2022
Figure 37. Latin America Anti-obesity Drugs Sales Market Share in Value by Application in 2022
Figure 38. Middle East and Africa Anti-obesity Drugs Sales Market Share in Value by Application in 2022
Figure 39. Key Raw Materials Price
Figure 40. Anti-obesity Drugs Manufacturing Cost Structure
Figure 41. Anti-obesity Drugs Industrial Chain Analysis
Figure 42. Channels of Distribution
Figure 43. Distributors Profiles
Figure 44. Bottom-up and Top-down Approaches for This Report
Figure 45. Data Triangulation
Figure 46. Key Executives Interviewed